Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Desmosomes01:05

Desmosomes

8.6K
The term desmosome derives from the Greek words "desmo" and "soma" meaning "adhesion bodies." This structure was first observed during the late 1800s and described as small, dense nodules in the epidermis. Desmosomes are button-like structures that help form an interlinked network of intermediate filaments across the cells. These junctions are  essential to hold cells together under mechanical stress and to maintain tissue integrity. Desmosomes are multi-protein...
8.6K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

741
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
741
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

695
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
695
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

602
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
602
Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

3.0K
Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
3.0K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

702
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
702

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Epicardial Contributions to Fibro-Inflammatory Signaling in a Pkp2-Deficient Arrhythmogenic Cardiomyopathy Model.

Circulation. Heart failure·2026
Same author

Effects of metabolic syndrome on cardiovascular outcomes in non-obese heart failure patients.

ESC heart failure·2026
Same author

Learning-based Pulmonary Disease Detection Using Weak Labels for Volume Sweep Lung Ultrasound Imaging.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Epicardial contributions to fibro-inflammatory signaling in a Pkp2-deficient arrhythmogenic cardiomyopathy model.

bioRxiv : the preprint server for biology·2025
Same author

New lung ultrasound system for rapid triage of pulmonary disease without a radiologist or sonographer.

BMC pulmonary medicine·2025
Same author

Left Ventricular Assist Devices: Advances, Complications, and Pitfalls.

Radiology. Cardiothoracic imaging·2025
Same journal

Multimodality imaging of myocardial injury and coronary microvascular dysfunction in congenital thrombotic thrombocytopenic purpura.

The international journal of cardiovascular imaging·2026
Same journal

Non-invasive imaging of atherosclerosis progression and cardiovascular outcome: a systematic review and meta-analysis.

The international journal of cardiovascular imaging·2026
Same journal

Cardiac MRI-based strain analysis for the assessment of left atrial dysfunction in patients with atrial fibrillation.

The international journal of cardiovascular imaging·2026
Same journal

Characteristics and outcomes of patients undergoing coronary computed tomography angiography for suspected acute coronary syndrome in the emergency department.

The international journal of cardiovascular imaging·2026
Same journal

Cardiac Troponin release, myocardial function and inflammation in patients with takotsubo syndrome: a cardiac magnetic resonance study.

The international journal of cardiovascular imaging·2026
Same journal

Photon-counting detector CT in cardiovascular imaging: technical advances, clinical applications, and future perspectives.

The international journal of cardiovascular imaging·2026
查看所有相关文章

相关实验视频

Updated: Mar 10, 2026

Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.
08:37

Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.

Published on: March 3, 2021

5.0K

德斯莫普拉金心肌病症 心肌病症

Daniel D Han1, Gregory Jew2, Katherine Kaproth-Joslin3,4

  • 1Medical Scientist Training Program, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.

The international journal of cardiovascular imaging
|March 9, 2026
PubMed
概括
此摘要是机器生成的。

德斯莫普拉金 (DSP) 心肌病是一种由DSP基因突变引起的遗传性心脏病,导致严重的心脏问题. 心脏MRI发现可能模仿其他心脏疾病,需要仔细诊断.

关键词:
德斯莫普拉金是心肌瘤学科的专家.

更多相关视频

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.3K
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.5K

相关实验视频

Last Updated: Mar 10, 2026

Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.
08:37

Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.

Published on: March 3, 2021

5.0K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.3K
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.5K

科学领域:

  • 心脏病学 心脏病学
  • 遗传学 遗传学 是一个
  • 医疗成像医学成像

背景情况:

  • 德斯莫普拉金 (DSP) 心肌病是一种遗传性心脏病.
  • 它源于desmosome基因DSP.中的突变.
  • 其后果包括心律失常,心力衰竭和突然的心脏死亡.

研究的目的:

  • 为了突出Desmoplakin (DSP) 心肌病的诊断挑战.
  • 为了区分其特有的心脏MRI发现与其他心肌疾病.

主要方法:

  • 对Desmoplakin (DSP) 心肌病的临床表现的审查.
  • 对心脏MRI特征的分析,特别是晚期加多增强模式.

主要成果:

  • 德斯莫普拉金 (DSP) 心肌病症呈现出心律失常和心力衰竭.
  • 心脏MRI通常显示出明显的环状心脏下垂体晚期加多增强.
  • 这种模式可能被误诊为心肌炎或脂肪透.

结论:

  • 准确诊断Desmoplakin (DSP) 心肌病非常重要.
  • 识别特定的心脏MRI"戒指"增强模式有助于区分.
  • 区分DSP心肌病与像心肌炎这样的模仿症对于适当的患者管理至关重要.